Literature DB >> 12083162

Summary of notifiable diseases--United States, 2000.

.   

Abstract

The MMWR Summary of Notifiable Diseases, United States, 2000 contains, in tabular and graphical form, the official statistics for the reported occurrence of nationally notifiable diseases in the United States for 2000. These statistics are collected and compiled from reports to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE).

Mesh：

Year:  2002        PMID： 12083162

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  15 in total

1.  Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.

Authors:  Sandra Romero-Steiner; Willie Spear; Nekeidra Brown; Patricia Holder; Thomas Hennessy; Patricia Gomez De Leon; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

3.  Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.

Authors:  Sandra Romero-Steiner; Patricia F Holder; Patricia Gomez de Leon; Willie Spear; Thomas W Hennessy; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 4.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Microbial evaluation and public health implications of urine as alternative therapy in clinical pediatric cases: health implication of urine therapy.

Authors:  Adenike Adedayo O Ogunshe; Abosede Oyeyemi Fawole; Victoria Abosede Ajayi
Journal:  Pan Afr Med J       Date:  2010-05-25

6.  Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001.

Authors:  Sharon L Roy; Stephanie M DeLong; Sara A Stenzel; Beletshachew Shiferaw; Jacquelin M Roberts; Asheena Khalakdina; Ruthanne Marcus; Suzanne D Segler; Dipti D Shah; Stephanie Thomas; Duc J Vugia; Shelley M Zansky; Vance Dietz; Michael J Beach
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.

Authors:  Diane M Janowicz; Kate R Fortney; Barry P Katz; Jo L Latimer; Kaiping Deng; Eric J Hansen; Stanley M Spinola
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms.

Authors:  Maria Labandeira-Rey; J Seshu; Jonathan T Skare
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings.

Authors:  Loretta Sweet Jemmott; John B Jemmott; Ann O'Leary
Journal:  Am J Public Health       Date:  2007-04-26       Impact factor: 9.308

Review 10.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.